前列腺癌部分腺体消融:重复治疗的效果
本研究评估中危前列腺癌患者重复部分腺体消融(PGA)的近期临床与病理效果。170例接受首次PGA后37例发现残留癌,其中30例接受第二次PGA;重复消融后生活质量评分与基线无显著差异,26例中14例(53%)活检无临床显著前列腺癌。
要点
- 首次PGA后37例发现残留癌,30例接受第二次PGA并纳入研究。
- 重复消融后生活质量评分与基线无显著差异,仅2/29报告决策后悔。
- 重复消融后26例中14例(53%)MRI引导活检无临床显著前列腺癌。
核心结论
- 首次PGA失败后,重复PGA是可考虑的合理选择,近期随访显示二次手术安全,对排尿和性功能仅造成轻微损害,约半数患者MRI引导活检临床显著前列腺癌不可检出。
研究设计与样本
- 170例中危前列腺癌(均为GG2或GG3)局灶病变患者在前瞻性试验中接受高强度聚焦超声(HIFU)或冷冻治疗(CRYO)的PGA。
- 首次PGA后37例发现消融区内或附近残留前列腺癌,其中30例接受第二次PGA并作为研究对象。
- 在基线、首次消融后6个月和第二次消融后6个月三个时间点进行生活质量问卷(IIEF、IPSS)和MRI引导活检(MRGB)。
主要发现
- 30例患者均完成生活质量问卷,26例在三个时间点完成MRGB。
- 首次或第二次PGA后平均生活质量评分与基线无显著差异。
- 未遇到手术并发症;重复消融后仅2/29例报告「决策后悔」。
- 25%患者报告精液量减少。
- 重复消融成功(MRGB无临床显著前列腺癌)为14/26例(53%)。
临床怎么用
- 作者认为,当初始PGA失败时,重复PGA是可考虑的合理选择。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the near-term clinical and pathological effects of repeat partial gland ablation (PGA) in men with intermediate-risk prostate cancer (PCa). MATERIALS AND METHODS: One hundred seventy men with focal lesions of PCa (all GG2 or GG3) underwent PGA with high-intensity focused ultrasound (HIFU) or cryotherapy (CRYO) in prospective trials. Residual PCa in or near the ablation zone was found in 37 men after a first PGA; 30 went on to receive a second PGA and were the subjects of study. At 3 timepoints, baseline and 6 months after first and second ablations, quality-of-life (QOL) questionnaires (IIEF, IPSS) and MRI-guided biopsies (MRGB) were performed. Biopsies were targeted and systematic at baseline and in follow-up, comprehensively about the ablation zone. RESULTS: All 30 patients completed QOL questionnaires and 26 had MRGB at the 3 timepoints. Mean QOL scores were not significantly different from the baseline after the first or second PGA. No operative complications were encountered; and "decisional regret" was reported in only 2/29 men after the repeat ablation. A decrease in semen volume was reported by 25% of patients. Repeat ablation was successful (absence of csPCa on MRGB) in 14/26 (53%) of men. PSA levels decreased and MRI lesions resolved after ablations, but neither was a reliable predictor of biopsy outcomes. CONCLUSION: When initial PGA fails, repeat PGA is a reasonable consideration, because in near-term follow-up, secondary procedures appear to be safe, causing only minimal detriment to urinary and sexual function, with csPCa becoming undetectable by MRGB in approximately half the patients.
引用
- Nassiri N, Richardson S, Kuppermann D, et al. Partial Gland Ablation of Prostate Cancer: Effects of Repeat Treatment. Urology. 2022. PMID: 35907484. doi:10.1016/j.urology.2022.07.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。